Sinitsyn, E.; Zykova, A.; Shamin, R.; Rvacheva, A.; Bogatyreva, A.; Yarovaya, E.; Kuzyakina, S.; Kutsenko, V.; Shapovalenko, T.; Stadnikova, A.;
et al. Ultra-Low-Dose Inhalation of Melphalan as an Additional Treatment for COVID-19-Associated Pneumonia. J. Clin. Med. 2025, 14, 2149.
https://doi.org/10.3390/jcm14072149
AMA Style
Sinitsyn E, Zykova A, Shamin R, Rvacheva A, Bogatyreva A, Yarovaya E, Kuzyakina S, Kutsenko V, Shapovalenko T, Stadnikova A,
et al. Ultra-Low-Dose Inhalation of Melphalan as an Additional Treatment for COVID-19-Associated Pneumonia. Journal of Clinical Medicine. 2025; 14(7):2149.
https://doi.org/10.3390/jcm14072149
Chicago/Turabian Style
Sinitsyn, Evgeny, Alexandra Zykova, Roman Shamin, Anna Rvacheva, Anna Bogatyreva, Elena Yarovaya, Svetlana Kuzyakina, Vladimir Kutsenko, Tatyana Shapovalenko, Antonina Stadnikova,
and et al. 2025. "Ultra-Low-Dose Inhalation of Melphalan as an Additional Treatment for COVID-19-Associated Pneumonia" Journal of Clinical Medicine 14, no. 7: 2149.
https://doi.org/10.3390/jcm14072149
APA Style
Sinitsyn, E., Zykova, A., Shamin, R., Rvacheva, A., Bogatyreva, A., Yarovaya, E., Kuzyakina, S., Kutsenko, V., Shapovalenko, T., Stadnikova, A., & Zykov, K.
(2025). Ultra-Low-Dose Inhalation of Melphalan as an Additional Treatment for COVID-19-Associated Pneumonia. Journal of Clinical Medicine, 14(7), 2149.
https://doi.org/10.3390/jcm14072149